NTRA-2112

N/A

Report date: 2025/06/07 20:00:15

Base Information

Drug NameNTRA-2112
Drug Alias NameNTRA-2112
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionReceptor protein-tyrosine kinase stimulantsOrnithine decarboxylase stimulants
TargetsReceptor protein-tyrosine kinaseOrnithine decarboxylase
Therapy Area/IndicationsPremature BirthMalabsorption Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesNetherlands +[10] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNutrinia Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesElgan Pharma Ltd
Active IndicationsN/A
Inactive IndicationsPremature BirthMalabsorption Syndromes

Other Information

ATC CodeN/A
Related LinksN/A